Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Hung

Showing results (111-120 of 205) with videos related to

Pageof 21
Sort By:
Sarcoma|January 1, 1997
Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory MechanismsR E Pollock, A Lang, A K El-Naggar, et al.
Oncogene|February 15, 2001
Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cellsS J Lim, G Lopez-Berestein, M C Hung, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene productsD Yu, T C Suen, D H Yan, et al.
Nature|November 23, 1995
Requirement for neuregulin receptor erbB2 in neural and cardiac developmentK F Lee, H Simon, H Chen, et al.
The Journal of Biological Chemistry|October 19, 2001
Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growthL Y Bourguignon, H Zhu, B Zhou, et al.
Cancer Research|January 26, 2000
Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cellsY Wen, D H Yan, B Spohn, et al.
Cancer Gene Therapy|May 1, 1996
Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancerX Xing, A Matin, D Yu, et al.
Endocrine-Related Cancer|September 21, 2005
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancersK-M Rau, H-Y Kang, T-L Cha, et al.
Cancer Letters|August 31, 1992
Oral cancer progression and c-erbB-2/neu proto-oncogene expressionL Hou, D Shi, S M Tu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986
Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic allelesM C Hung, A L Schechter, P Y Chevray, et al.
Pageof 21

Showing results (111-120 of 205) with videos related to

Sort By:
Pageof 21
Sarcoma|January 1, 1997
Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory MechanismsR E Pollock, A Lang, A K El-Naggar, et al.
Oncogene|February 15, 2001
Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cellsS J Lim, G Lopez-Berestein, M C Hung, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene productsD Yu, T C Suen, D H Yan, et al.
Nature|November 23, 1995
Requirement for neuregulin receptor erbB2 in neural and cardiac developmentK F Lee, H Simon, H Chen, et al.
The Journal of Biological Chemistry|October 19, 2001
Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growthL Y Bourguignon, H Zhu, B Zhou, et al.
Cancer Research|January 26, 2000
Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cellsY Wen, D H Yan, B Spohn, et al.
Cancer Gene Therapy|May 1, 1996
Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancerX Xing, A Matin, D Yu, et al.
Endocrine-Related Cancer|September 21, 2005
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancersK-M Rau, H-Y Kang, T-L Cha, et al.
Cancer Letters|August 31, 1992
Oral cancer progression and c-erbB-2/neu proto-oncogene expressionL Hou, D Shi, S M Tu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1986
Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic allelesM C Hung, A L Schechter, P Y Chevray, et al.
Pageof 21